The purpose of this study was to clarify the relationship between the cellular and humoral immune components in the pathogenesis of vitiligo vulgaris. By using cytokines as indicators of peripheral mononuclear cell (MNC) function, we compared the effects of phytohemagglutinin (PHA) and purified IgG on MNCs derived from patients suffering from active vitiligo with those from normal controls. The results revealed (i) a significant increase in spontaneous production of IL-6 and IL-8 in patients; (ii) PHA, purified IgG from patients (IgG-anti-MC), or IgG from normal controls (N-IgG) induced a significant increase in IL-6 but diminished GM-CSF, TNF-a, and IFN-l' release in patients; and (iii) IgG-anti-MC brought about a significantly higher stimulatory effect on IL-l/3 and IFN-l' production than N-IgG in Reprin t requests to : J r. Yu , H sin-Su , De partment of Dcrmatology. Kao hsiung Medical College, 100 Shih C huan First R oad , Kaohsiung, Truwan 80708 .
The purpose of this study was to clarify the relationship between the cellular and humoral immune components in the pathogenesis of vitiligo vulgaris. By using cytokines as indicators of peripheral mononuclear cell (MNC) function, we compared the effects of phytohemagglutinin (PHA) and purified IgG on MNCs derived from patients suffering from active vitiligo with those from normal controls. The results revealed (i) a significant increase in spontaneous production of IL-6 and IL-8 in patients; (ii) PHA, purified IgG from patients (IgG-anti-MC), or IgG from normal controls (N-IgG) induced a significant increase in IL-6 but diminished GM-CSF, TNF-a, and IFN-l' release in patients; and (iii) IgG-anti-MC brought about a significantly higher stimulatory effect on IL-l/3 and IFN-l' production than N-IgG in E Vid e n ce supportm g tlus h y p o theSIS Includes (I) vmh go is o ccasionall y a ssoc ia te d with certain ,lutoimmune di so rd e rs (Za uLi et ai, 1 986; H egedu s el ai , 1 994) , (ii) p resen ce of c irc ula tin g o r gan-sp ecific a u toantibo di es (C unLiffc e/ al; 1 968; H a.rso ul as e/ ai, 197 8; B e tte rl e el ai, 1 985), (iii ) occurre n ce o f m e la n ocyte-sp ecifi c antib o dies (N a u g hto n et ai, 1983 a , 1 983 b) , and (iv ) a b e rration s in t h e proporti.on o f T -cell subp o pulatio n s (So ubiran eI ai , 1985; G rim es et ai, 1986 ; D 'Am e lio e/ ai, 1 990 ; Mo zzani ca el (/1 , 1990 ; H ann et (/1 , 1.9 93; Al-Fou z an el ai, 1 995 ) . Of these, t h e presen ce o f anti-m e lanocyte antibo di es a nd imbal a n ce in p e tiph eral m o n o nuclear cell (MN C ) subsets m ay play p artic ularl y imp o r tant ro les in th e pathogen esis of vitili go. A nti-m c lan ocyte a ntib o di e~ w ere fo und t o induce m e la n ocyte damage in vi/ro b y a comple m e n tmediate d m ech a ni sm and antibody-de p e nde nt ce llular cyto toxic ity (N o rri s et ai, 1988 ) . A lt hou g h a lter a tions in MN C subpo pul a ti o n s. esp ecially in T ly mph ocyt e s, h ave b een th e subj ect o f inte n sive Mannscript received Scptember 23 1996; revised December 19, 1996 ; accepted for publica ti on D ece mber 30, 1996 . Reprin t requests to : J r. Yu , H sin-Su , De partment of Dcrmatology. Kao hsiung Medical College, 100 Shih C huan First R oad , Kaohsiung, Truwan 80708 .
Abbreviations: IgG -anti-MC. IgG anti-melan ocytc an ti bodies; N-l gG, pu ri fied IgG fro m normal con trols; MN C . m ononucl ea r cell. normal controls. Imluunologically, IL-6 can enhance melanocyte ICAM-l expression, which may increase leukocy te-n1.elanocyte attachment and cause melanocy te damage in vitiligo. A decrease in GM-CSF (an intrinsic growth factor for melanocyte) production may retard recovery from vitiligo by checking the proliferation of surviving melanocytes. A significant decrease in TNF-a and IFN-l' production may partially explain the reduced inflammatory reaction in vitiliginous lesions. That I gG-anti-MC stimulates an increase in IL-l/3 and IFN-y production in controls suggests that IgG-anti-MC may play a role in mela- 
M ATEIUALS AN D METH ODS
Sele ction of Patients Twe lve pati ents with vitiligo of non-segmentaJtype were selected in this study. All patien ts h ad developcd newly dcp igmcnced lesions w ithin the previous 3 mo; that is, they were suffering fro m acti vc viti ligo (M ocllmaltn e( nl, 1982) . None of the paticncs had an y known a u to inUl11111 C d isord ers such as H as hillloto ' s th yro id itis, Grave 's disease, pernicious anem ia, or insulin-depcndent diab etes m elli tus. An equ al number of age-an d sex-matched hea.l thy individu als served as con trols for the prcsent study . None of the parti cipants had received m edical treatm cnt in the prececdin g 3 m o .
Purification of I g G from Serum of Vitiligo Patient s with AntiMelanocyte Antibodies Se rum fro m patients with active vitiligo 'llld no rmal contro ls was co llected for purificatio n . T hc fraction II (lgG) o btained fro m Scphacryl S-300 ge l fi ltration was further absorbed into the protein A-Seph arosc 4B (Pharmacia LKB. Uppsa la, Sweden). Sepharoseconju gatcd IgG was clu tcd w ith soclium acetate bu ffe r at pH 2.5 and imm cdiately ncutralized to pH 7.2 with 1 N N aOH . After adequate dialysis aga inst disti llcd watcr, the IgG was lyophil ized (Yu et nl. 1989a) . T he pro tein concentration of pur ifie d IgG was dcrcn11ined by Dio-Ra d protein assay kit (Bio-R ad, Kichmond. A). 19G preparations were fo und to be free Melanocyte Culture and IgG Anti-Melanocyte Antibody Detection Normal adult human foreskin was employed for melanocyte culture.
Melanocytes were isolated and maintained in culture as described (Kao and Yu, 1991) . Second-passage cells were used for IgG anti-melanocyte antibody (lgG-anti-MC) detection. T he individual purified IgG was meas ured for anti-m elanocyte activity by cellul ar enzyme-linked immunoso rbent assay (ELISA) as reported (Yu ct aI, 1993) . Six sampl es containin g the highest titer of IgG-anti-MC were tI,en used in the foll owing ex'Veriments.
Isolation of Peripheral MNCs and Preparation of MNC Supernatants Peripheral MN Cs were isolated from heparinized veno us blood of patients and normal individuals by cenrrifuging at 300 X g for 30 min ove r a Fico ll-Hypaque cushi on (specific gravity, 1.077) as reported (Yu ef aI, 1989b) . The cell concentration was adjusted to 2 X 10" cells per ml in 100;., feta l bo vine serum in [lPMI 1640 medium (GIBCO, Ga ith ers burg, MD) . Fifty microHters of MN Cs were pl aced in triplicate microwcll s. Tben, 0.02 mJ of 10% fetal bov in e serum in [lPMI 1640 medium (spontan eo us), .PI-IA (5 J.l.g per ml , Sigma, St. Louis, MO) , IgG-anti-M C (100 J.l.g per ml) or normal IgG (N-lgG) (100 J.l.g per ml), and 0.13 ml of 10% fetal bov in e serum in RPMI 1640 medium was added to the mi crowe lls. T he mixture was in cubated at 37°C in 5% C0 2 /95% air for 24 h . After incubati on, tb e mixture was centrifuged at 2000 rpm for 10 min and the cell-free supematants were collected and stored at -20°C until cytokinc detcmlination.
Measurement of Cytokil1es in MNC Supernatants by ELISA The concentra tio n of cytokines in the culture supematanrs derived fro m 1 X 10" MN Cs per m l after a 24-b incubation with medium , PHA, IgG-anti-MC, or THE JOURNAL OF INVESTIGATIVE DERMATOLOGY N-l gG was measured by commercially available ELISA test kits. T he ELISA ki ts includ e in terieukin (IL)-l/3, lL-6, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor-a (TNF-a), and illterferoll-y (IFN-y) (Research and Develop System, Minneapolis, MN), and we foll owed the manu f.1cturer's in struction. p < 0.05). In contra st, di1feren ces in the sp o ntan eo us IL-1 /3, GM-CSF, TNF-a, and IFN-)' release were not sig nificant (Table   I ).
PHA, IgG-anti-MC, and N-IgG Indnced a Higher IL-6 Production but Lower GM-CSF, TNF-a, and IFN-y Release in the Patient Group as Compared with the Control Group A s de monstrate d in Table I , PHA, IgG-anti-MC, or N-IgG induced a signifi cant inc rease in IL-6 production , a nd a decrease in GM-CSF, TNF-a, an d IFN-)' release were found in p atients with active vi tiligo as compa re d with controls. Mo reover, I gG-anti-MC induced signifI ca ntly high e r IL-1/3 produ ction in contro ls than in patie nts (p < 0.05). PHA-or N-I gG -stimul a ted IL-1/3 production was similar b etween p atients and normal controls. A n addition al ulteresting findin g was that IgG-a nti-MC in con trols had a significa ntly high e r stimulatOl'Y eff:ect o n IL-l/3 (p < 0.005) and fFN-)' (p < 0 .05) produ ction tban did N-IgG.
DISCUSSION
M elanocytic cytoto xicity of immune me c hani sm s in vitiligo is a co mpl ex process ulVolvin g e ffector-tar get attachment v ia pairs of adh esive m o lecttles, activatio n of le ukocyte receptors by tar get antigens and other cell-surfuce m arke rs, and triggering of cytolysis (Martz, 1987; Norris, 1990 ; Morelli a nd Norris , 1993) . AI Badri el at (1 993) reported increased el'.'Pressio n of inte rceJlui ar adh esio n Table I molec ul e 1 (r CAM-l) o n m elanocytes in active vitili go lesio ns. IC AM-1 is necessa ry fo r leukocyte-melanocyte attachment that develo ps in to immuno logic cytotoxicity (M orelli and N OI:ri S, 1993) . M an y cyto kin es such as I FN -y, T N F-a, T N F-,B, IL-1, IL-6, and lL-7 can induce th e expression o f cell surface IC AM-1 o n melan ocytes (Yohn et aI, 1990 , Ki rnbauer el al, 1992 ) . In thi s study, IL-6 producti on o fMN Cs was fo und to be significa ntly increased in pa ti ents w ith vitili go. It is not inconceivable th at thi s cytokin e not only enhances m elan ocyte l CAM-l expressio n , w hich m ay tri gger leukocyte-m elan ocyte attachmen ts, but also induces polyclo n al B-cell activa tio n , increasing auto antibo dy pro du ction and ca using melanocyte dam age in vitiligo. In addi tio n , increased IL-8 produ ction by pati ents acti va ted m o nocytes ma y be able to attract polymorphonuclear neutro phils (Yoshimura et aI, 1987) and T lymphocytes (Larsen et ai, 1989) to th e sites of lesio ns, amplifYin g infl ammatory reacti ons and, therefore, facilitating m elan ocytic cytotoxicity. An o th er interesting fi ndin g in this study is a decrease in the produ ctio n of G M-C SF, T N F-a, and IFN-y by MN Cs in pati ents wi th active vitiligo . GM-C SF had been repo rted as an intrinsic fac to r fo r m elan ocyte g ro wth (lmo kawa et aI, 1996) . A sig nifi can t decrease in G M-C SF release in acti ve vitiligo m ay retard th e prolife ratio n o f survi vin g melano cytes and reco very fro m vi tiligo . TNF-a has been implicated as a fund am ental inflammato ry m ediator (Vlassa ra et aI , 1988; Tracey et aI, 1989 ) and IFN-y as an immuno m odulator (Trin chi eri et aI, 1985) . A signifi can t decrease in TNF-a and IFN-y produ ctio n by m o no nu clear cell s in acti ve v itiligo ma y partially expl ain the redu ced inflammatory reaction and ~ell infiltrati o n (Moellilla nn et aI, 1982; Kao and Y u, 1990 ) in lesions.
By u sin g cultured m elanocytes as a substrate, cellular ELI SA revea led a hi gher o pti cal den sity for IgG-an ti-MC as compared to N -IgG . On the other h and, IgG-an ti -MC and N-IgG exllibited a p oten t stimulato ry effect 0 11 cy tokine produ ctio n by MN Cs both in patients with ac ti ve vitili go and in n o rmal individu als. T his m ay indica te th at MNCs per se are n ot the uniqu e tar get cell s for IgG-anti-M C. IgG-anti-M C, h owever, h ad a signifi cantl y hi gher stimulatory effect o n IL-l,B and IFN -y produ cti o n than did N-rgG in n o rmal con tro ls. Since IFN -y stimulates IL-l ,B pro du ctio n by monocytes and major hi stocompatibility complex class r and class II expressio n o n m any cell s, IgG-anti-M C m ay play a role in the inflammatory and immuno logic processes of m elanocyte destru ction m ediated by monocytes .
An increase in the pro du cti on o f proin fl ammatory cyto kines, th at is, IL-6 and IL-8, by th e MNCs of active vitiligo patients m ay play an impo rtan t role in m elanocytic cytotoxicity thro ugh th e enhan cement of e ffecto r cell mi grati o n and e ffectOl·-targe t attachmen t. 
